SFS
AXDX

Sowell Financial Services’s Accelerate Diagnostics AXDX Stock Holding History

Sowell Financial Services’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60
Closed -$4K – 706
2021
Q1 		$4K Hold
60
– – ﹤0.01% 2644
2020
Q4 		$5K Hold
60
– – ﹤0.01% 2257
2020
Q3 		$6K Hold
60
– – ﹤0.01% 1937
2020
Q2 		$9K Hold
60
– – ﹤0.01% 1717
2020
Q1 		$5K Hold
60
– – ﹤0.01% 1802
2019
Q4 		$10K Hold
60
– – ﹤0.01% 1675
2019
Q3 		$11K Buy
+60
New +$11.6K ﹤0.01% 1493
2017
Q1 		– Sell
-22
Closed -$5K – 275
2016
Q4 		$5K Buy
+22
New +$5.22K ﹤0.01% 532

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sowell Financial Services's AXDX Position: Q2 2021 in Review

Sowell Financial Services sold out of Accelerate Diagnostics (AXDX) in Q2 2021, closing a stake of 60 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in AXDX in Q4 2016 and held it in 8 quarters. The position peaked at $11K in Q3 2019. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2021.

  • Sowell Financial Services reported no remaining Accelerate Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 60 Accelerate Diagnostics shares in Q2 2021, an estimated $4K.
  • Sowell Financial Services first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 8 quarters.
  • Sowell Financial Services's Accelerate Diagnostics position peaked at $11K in Q3 2019.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.